1. Bail‐out treatment of pulmonary embolism using a large‐bore aspiration mechanical thrombectomy device
- Author
-
Stefan Stadler, Samuel Sossalla, Lars S. Maier, Markus Ritzka, and Kurt Debl
- Subjects
medicine.medical_specialty ,Thrombus aspiration ,medicine.medical_treatment ,610 Medizin ,Case Report ,Case Reports ,Pulmonary embolism ,Large-bore aspiration mechanical thrombectomy device ,FlowTriever ,Veno-arterial ECMO ,Internal medicine ,medicine ,Extracorporeal membrane oxygenation ,Diseases of the circulatory (Cardiovascular) system ,Veno‐arterial ECMO ,Large‐bore aspiration mechanical thrombectomy device ,ddc:610 ,Ventricular function ,business.industry ,Acute right heart failure ,Thrombolysis ,medicine.disease ,Mechanical thrombectomy ,surgical procedures, operative ,Heart failure ,RC666-701 ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
We report on the first pulmonary embolism treatment via the large‐bore aspiration mechanical thrombectomy device (Inari FlowTriever®) outside the USA, in a resuscitated patient on veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) suffering from severe and acute right heart failure. In this particular high‐risk patient population, where thrombolysis is mostly not applicable, this new technology could be a promising solution as the combination of large‐bore thrombus aspiration and extraction successfully removes large emboli. In our case, right ventricular function improved rapidly after the procedure, ECMO could be weaned, and the patient was dismissed 2 weeks after. In summary, we provide a new therapeutic option for the often difficult treatment of pulmonary embolism in high‐risk patients on VA‐ECMO.
- Published
- 2021